Fundraising FoxNeoTract
Pleasanton, US · Delaware corporation · 3 known investors
Find your way into NeoTract
Sign up to see every warm intro you have to NeoTract
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeoTract team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TL
Ted LamsonFounder & Chief Technical Officer2009–2019Ted Lamson has over 25 years of experience in medical device development, working across interventional cardiology, catheter-based therapies, stem cell technology, ENT, and urology. He co-founded NeoTract and co-invented the UroLift treatment through the ExploraMed incubator; following Teleflex's acquisition of NeoTract, he continues to consult and serve on startup boards.
DA
David AmersonExecutive
WF
William FacteauExecutive
JM
TL
Theodore LamsonFounder
Board
RD
KK
Kadir KadhiresanBoard director
FM
Frank M. TortiBoard director
JN
John NehraBoard director
RW
Robert W. CroceBoard director
RK
Robert K. AndersonBoard director
Investors · 3
New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Johnson & Johnson Innovation – JJDCreportedNew Brunswick
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$63.4M disclosed across 2 rounds · 2012–2016
▶$12.8MraisedJan 2017 · 12 investors · Other Health CareRule 506(b)
▶$12.8MraisedJan 2017 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Theodore LamsonDirector
- Robert W. CroceDirector
- Robert K. AndersonDirector
- Ryan DrantDirector
- David AmersonExecutive Officer, Director
- Kadir KadhiresanDirector
- William FacteauDirector
- Joshua MakowerDirector
- Frank M. TortiDirector
- Offering amount
- $15M
- Amount sold
- $12.8M
- Minimum investment
- $1
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50.6MraisedJan 2014 · 71 investors · Other Health CareRule 506(b)
▶$50.6MraisedJan 2014 · 71 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David AmersonExecutive Officer, Director
- Ryan DrantDirector
- William FacteauDirector
- Kadir KadhiresanDirector
- Theodore LamsonDirector
- John NehraDirector
- Robert AndersonDirector
- Robert CroceDirector
- Joshua MakowerDirector
- Offering amount
- $56.7M
- Amount sold
- $50.6M
- Minimum investment
- $1
- First sale
- May 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
5 people who came through NeoTract went on to found or lead other companies.
Joshua MakowerDirectorFounded ExploraMed V +1Eb BrightGeneral Counsel and VP, Intellectual PropertyFounded Revelle AestheticsRebecca Alvarez StoryClinical & Regulatory SpecialistFounded BloomiChristopher GleasonArea Sales DirectorFounded MoximedRichard S. WalshVice President of SalesFounded Corvent Medical
Frequently asked questions
- Who founded NeoTract?
- NeoTract was founded by Ted Lamson.
- Who are NeoTract's investors?
- NeoTract's investors include New Enterprise Associates (NEA), Windham Capital Partners, Johnson & Johnson Innovation – JJDC.
- How much funding has NeoTract raised?
- NeoTract has disclosed $63.4M raised across 2 rounds.
- Where is NeoTract headquartered?
- NeoTract is headquartered in Pleasanton, US.